Interactive Session - Contraception Day: CSIG-HDSIG Interactive Session - Contraceptive Strategies for Disadvantaged Women
Time:1:15 pm - 2:15 pm
Location:HCC316 - Hawaii Convention Center
Alicia Y. Armstrong, M.D. (Chair), National Institutes of Health
Bliss Kaneshiro, M.D., M.P.H., University of Hawaii
David F. Archer, M.D., Eastern Virginia Medical School
Tessa Madden, M.D., M.P.H., Washington University School of Medicine
Supported by an educational grant from Merck
(Alternate Panel - Letterman)
Needs Assessment and Description
Unintended pregnancies are a worldwide problem and disproportionately impact disadvantaged women. Globally, 86 million pregnancies were unintended, of which 41 million ended in abortion, 33 million unplanned births, and 11 million miscarriages. Healthcare providers, policy makers, and basic scientists involved in contraceptive research all play an important role in identifying effective contraceptive options and making them available to all women, particularly disadvantaged women.
At the conclusion of this session, participants should be able to:
- Identify major barriers to contraceptive access among disadvantaged women.
- Describe several strategies for improving contraceptive access among disadvantaged women.
A 34-year-old woman presents with symptomatic leiomyomata (which do not distort the uterine cavity) and mild anemia. She is recently postpartum and does not plan to have additional children for at least 3 years. She is uninsured and has an income of less than $25,000 a year. After participating in this session, in my practice I will recommend the following contraceptive option to provide the lowest failure rate, greatest noncontraceptive benefits, and be the most cost-effective:
a. Combined oral contraceptives
b. Depot medroxyprogesterone
c. Levonorgestrel-containing intrauterine device (IUD)
d. Contraceptive implant
e. Contraceptive vaginal ring
f. Not applicable to my area of practice